Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
carboplatin (paraplatin) (1 trial)
enfortumab vedotin (Padcev) (1 trial)
paclitaxel (taxol) (1 trial)
pembrolizumab (keytruda) (1 trial)
tea (1 trial)
Fallopian Tube Neoplasms (Phase 2)
Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 2)
Trials (3 total)
Trial APIs (5 total)